These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34693385)

  • 1. Tuberculosis endotypes to guide stratified host-directed therapy.
    DiNardo AR; Nishiguchi T; Grimm SL; Schlesinger LS; Graviss EA; Cirillo JD; Coarfa C; Mandalakas AM; Heyckendorf J; Kaufmann SHE; Lange C; Netea MG; Van Crevel R
    Med; 2021 Mar; 2(3):217-232. PubMed ID: 34693385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.
    Restrepo BI
    Tuberculosis (Edinb); 2016 Dec; 101S():S69-S72. PubMed ID: 27720378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies.
    Tiwari D; Martineau AR
    Semin Immunol; 2023 Jan; 65():101672. PubMed ID: 36469987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.
    Zumla A; Rao M; Dodoo E; Maeurer M
    BMC Med; 2016 Jun; 14():89. PubMed ID: 27301245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-directed therapy against tuberculosis: Concept and recent developments.
    Udinia S; Suar M; Kumar D
    J Biosci; 2023; 48():. PubMed ID: 38088376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.
    Zhao L; Fan K; Sun X; Li W; Qin F; Shi L; Gao F; Zheng C
    Front Immunol; 2023; 14():1305325. PubMed ID: 38259491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host factors subverted by
    Kalra R; Tiwari D; Dkhar HK; Bhagyaraj E; Kumar R; Bhardwaj A; Gupta P
    Int Rev Immunol; 2023; 42(1):43-70. PubMed ID: 34678117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and Challenges for Host-Directed Therapies in Tuberculosis.
    Sachan M; Srivastava A; Ranjan R; Gupta A; Pandya S; Misra A
    Curr Pharm Des; 2016; 22(17):2599-604. PubMed ID: 26818871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies.
    Putera I; Schrijver B; Ten Berge JCEM; Gupta V; La Distia Nora R; Agrawal R; van Hagen PM; Rombach SM; Dik WA
    Prog Retin Eye Res; 2023 Jul; 95():101189. PubMed ID: 37236420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remembering the Host in Tuberculosis Drug Development.
    Frank DJ; Horne DJ; Dutta NK; Shaku MT; Madensein R; Hawn TR; Steyn AJC; Karakousis PC; Kana BD; Meintjes G; Laughon B; Tanvir Z
    J Infect Dis; 2019 Apr; 219(10):1518-1524. PubMed ID: 30590592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can We Exploit Inflammasomes for Host-Directed Therapy in the Fight against
    Cebani L; Mvubu NE
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products in anti-tuberculosis host-directed therapy.
    Huang X; Lowrie DB; Fan XY; Hu Z
    Biomed Pharmacother; 2024 Feb; 171():116087. PubMed ID: 38171242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis.
    Ayodele S; Kumar P; van Eyk A; Choonara YE
    Biomed Pharmacother; 2023 Jun; 162():114588. PubMed ID: 36989709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients.
    Domaszewska T; Zyla J; Otto R; Kaufmann SHE; Weiner J
    Front Immunol; 2021; 12():694680. PubMed ID: 34421903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.